Withings’ devices will connect to Medable’s clinical trial platform and capture and collect important patient data from heart rate to sleep patterns, according to the July 21 press release. The design is non-invasive and user friendly in an attempt to ease use for patients and encourage retention of their engagement in the trial, which is a major issue in the industry.
“As the industry leader in plug-and-play connected sensor devices, Withings is the ideal partner for Medable as we continue driving for population representation in clinical trials,” said Michelle Longmire, MD, co-founder and CEO of Medable. “Their devices are a critical part of a successful decentralized clinical trial and we look forward to a long, successful partnership with Withings.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
